Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
06/1996
06/20/1996CA2204130A1 Tachykinin antagonists
06/19/1996EP0717044A1 Thienopyridone derivatives, their preparation and their use as NMDA-receptor antagonists
06/19/1996EP0717043A1 Use of 1,2-bridged 1,4-dihydropyridines as selective potassium channel modulators
06/19/1996EP0717036A1 Use of 5-acyl-1,4-dihydropyridines for the treatment of diseases of the CNS
06/19/1996EP0716696A1 Uses of myelin oligodendrocyte glycoprotein and peptide portions thereof in protocols related to autoimmune disease
06/19/1996EP0716661A1 Pseudo- and non-peptide bradykinin receptor antagonists
06/19/1996EP0716657A1 ALKOXY-SUBSTITUTED $g(b)-CARBOLINES ACTING ON THE AMPA-RECEPTOR
06/19/1996EP0716650A1 Indole and indoline derivatives as 5ht1d receptor antagonists
06/19/1996EP0716649A1 5-arylindole derivatives
06/19/1996EP0716610A1 Neural regeneration using human bone morphogenetic proteins
06/19/1996EP0716603A1 Methods and compositions for inhibiting uridine secretion
06/19/1996EP0716602A1 The primary and secondary neuroprotective effect of flupirtine in neurodegenerative diseases
06/19/1996EP0520024B1 Quinoxaline compounds and their preparation and use
06/19/1996CN1124961A Substituted pyrrolidin-3-Yl-alkyl-piperidines useful as tachykinin antagonists
06/19/1996CN1124960A Indole derivatives as 5-HT1A and/or 5-HT2 ligands
06/19/1996CN1124953A Aromatic acetylcholinesterase inhibitors
06/19/1996CN1124635A Epilepsy decoction
06/18/1996US5527822 Administering butyrolactone derivatives
06/18/1996US5527817 N,n-dimethyl-2-(5-(1,2,4-triazol-1-ylmethyl)-1h-indol-3-yl) ethylamine; selective agonist of 5-ht1-like receptors; useful in treatment of migraines
06/18/1996US5527814 Use of 2-amino-6-(trifluoromethoxy)benzothiazole for obtaining a medicament for the treatment of amyotrophic lateral sclerosis
06/18/1996US5527808 Fused tricyclic nitrogen containing heterocycles
06/17/1996CA2165386A1 2-amino-1,3-thiazepines and their use as inhibitors of nitric oxide synthase
06/17/1996CA2165131A1 Use of 1,2-bridged 1,4-dihydropyridines as medicaments
06/17/1996CA2165130A1 Use of 5-acyl-1,4-dihydropyridines
06/16/1996CA2165129A1 Thienopyridones
06/13/1996WO1996017924A2 Novel hedgehog-derived polypeptides
06/13/1996WO1996017865A2 Genes and gene products for use in the diagnosis of degenerative nerve damage
06/13/1996WO1996017842A1 Azetidine, pyrrolidine and piperidine derivatives as 5ht1 receptor agonists
06/13/1996WO1996017831A1 Uracil derivatives
06/13/1996WO1996017611A1 Pharmaceutical composition comprising lamotrigine
06/13/1996WO1996009038A3 Alteration of activity and/or levels of haem-oxygenase to control inflammation
06/13/1996DE19514522C1 Sauerstoffanionradikale enthaltende therapeutische Mittel und deren Verwendung zur Schmerzbehandlung Sauerstoffanionradikale containing therapeutic agents and their use for the treatment of pain
06/13/1996CA2207284A1 Pharmaceutical composition comprising lamotrigine
06/13/1996CA2207201A1 Azetidine, pyrrolidine and piperidine derivatives as 5ht1 receptor agonists
06/13/1996CA2206994A1 Genes and gene products for use in the diagnosis of degenerative nerve damage
06/12/1996EP0716081A1 Highly selective process for the preparation of enantiomerically pure phenyl-substituted 1,4-dihydropyridine-3,5-dicarboxylic acid derivatives
06/12/1996EP0715851A2 Substituted phenylpyrimidine derivatives, useful in the treatment of prevention of CNS disorders
06/12/1996EP0715624A1 Process for the preparation of benzodiazepine compounds useful as antagonists of cck or of gastrine
06/12/1996EP0715620A1 1-arylcycloalkyl sulphides, sulphoxides and sulphones for the treatment of depression, anxiety and parkinson's disease
06/12/1996EP0715517A1 Estrene steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions and methods
06/12/1996EP0503044B1 Peptide compounds of laevorotatory amino acids and ring molecules, and therapeutical applications thereof
06/12/1996EP0422134B1 5-ht selective agents
06/12/1996CN1124489A Tetracyclic compounds as dopamine agonists
06/12/1996CN1124485A Novel 1-phenylalkanone 5-HT4 receptor ligands
06/12/1996CN1124484A 3-(indol-3-YL) propenoic acid derivatives and as NMDA antagonists
06/12/1996CN1124454A Rectal compositions
06/12/1996CN1032000C Process for preparing pyrazolidinone CCK and gastrin antagonists
06/12/1996CN1031999C Process for preparing 6-substituted-tetrahydrobenz |CD¨ indoles
06/12/1996CN1031998C |Alpha-(tert-butyl aminomethyl)-3,4-dichloro benzyl¨ thioacetamide, process for preparing them and application
06/11/1996US5525631 Compositions of the ethyl ester of L-DOPA
06/11/1996US5525624 A 3-benzoyl,4-oxyphenylbenzothiophene compound
06/11/1996US5525619 Inhibitors of monoamine oxidase b
06/11/1996US5525614 Substituted 1,2,3,4-tetrahydroisoquinolines with angiotensin II receptor antagonist properties
06/11/1996US5525613 Covalently coupled benzoylecgonine ecgonine and ecgonidine
06/11/1996US5525600 Compound useful as antipsychotic, antidepressant and anxiblytic agents
06/11/1996US5525467 Detection, diagnosis, therapy of alzheimer's disease
06/06/1996WO1996016981A2 Peptide compounds for prevention and/or treatment of no-mediated diseases
06/06/1996WO1996016961A1 (thiophen-2-yl)-piperidin or tetrahydropyridin carboxamides
06/06/1996WO1996016949A1 Novel 3,5-dioxo-(2h,4h)-1,2,4-triazine derivatives, their preparation and use as drugs
06/06/1996WO1996016939A1 Perhydroisoindole derivatives as antagonists of substance p
06/06/1996WO1996016934A1 Substituted biphenyl compounds for the treatment of inflammation
06/06/1996WO1996016670A1 New therapeutical utilization of superoxide dismutases
06/06/1996WO1996016668A1 Novel hedgehog-derived polypeptides
06/06/1996WO1996016542A1 Methods of modifying feeding behavior, compounds useful in such methods, and dna encoding a hypothalamic atypical neuropeptide y/peptide yy receptor (y5)
06/06/1996CA2206257A1 Substituted biphenyl compounds for the treatment of inflammation
06/06/1996CA2206142A1 New therapeutical utilization of superoxide dismutases
06/06/1996CA2205584A1 (thiophen-2-yl)-piperidin or tetrahydropyridin carboxamides
06/05/1996EP0714910A1 Use of a decapeptide with a benzodiazepine activity for the preparation of medicaments and dietary supplements
06/05/1996EP0714896A1 Indol derivatives useful for the treatment of migraine, composition and utilization
06/05/1996EP0714895A1 Pyrrole derivatives
06/05/1996EP0714894A1 3-(1,2,3,6-tetrahydro-(1-alkylenearyl)-4-pyridinyl)- and 3-(1-alkylenearyl)-4-piperidinyl-1h-indoles: new 5-HT1f agonists
06/05/1996EP0714883A1 Aryloxypropanolamine beta 3 adrenergic agonists
06/05/1996EP0714663A2 Potentiation of drug response by a serotonin 1A receptor antagonist
06/05/1996EP0714660A1 Ranolazine and related piperazines for protecting skeletal muscles
06/05/1996EP0714511A1 Methods of detecting and combating disorders of the central nervous system
06/05/1996EP0714395A1 Vasoconstrictive substituted dihydropyranopyridines
06/05/1996EP0714394A1 Antipsychotic method
06/05/1996EP0714389A1 Amide and urea derivatives as 5ht1d receptor antagonists
06/05/1996EP0714388A1 Vasoconstrictive substituted aryloxyalkyl diamines
06/05/1996EP0714300A1 Methods for modulating the human sexual response
06/05/1996EP0714296A1 Flavonoid and biflavonoid derivatives, their pharmaceutical compositions, their anxiolytic activity
06/05/1996EP0714294A1 Pharmaceutical compositions comprising metal complexes
06/05/1996EP0460169B1 New chroman and thiochroman derivatives
06/05/1996CN1124040A Adenoviral vectors of animal origin and use thereof in gene therapy
06/05/1996CN1124026A Thioindole pyperidinyl derivatives used as antalgics
06/05/1996CN1123691A Zengzhiling capsule for intelligence development and its production
06/05/1996CN1123690A Naoxuekang capsule for curing cerebrovascular disease and its production
06/05/1996CN1123689A Xiansukang capsule for curing epilepsy and its production
06/04/1996US5523475 2-nitro-3-hydroxybenzoic acids as enzyme inhibitors of 3-hydroxyanthranilate oxygenase active in producing the neurotoxin, quinolinic acid
06/04/1996US5523455 Prepared using a naphthylhydrazine chemical intermediate
06/04/1996US5523314 Compounds useful as hypoglycemic agents and for treating Alzheimer's disease
06/04/1996US5523306 Amino acid derivatives cyclized at the C-terminal
06/04/1996US5523299 Administering in treatment of psychotic disorders
06/04/1996US5523294 Di-lysoganglioside derivatives
06/03/1996CA2164246A1 Aryloxypropanolamine beta 3 adrenergic agonists
06/02/1996CA2163490A1 Pyrrole derivatives
06/02/1996CA2161209A1 3-<1,2,3,6-tetrahydro-<1-alkylenearyl>-4-pyridinyl>- and 3-<1-alkylenearyl>-4-piperidinyl-1h-indoles: new 5-ht1f agonists
05/1996
05/30/1996WO1996016087A1 G-protein coupled receptor
05/30/1996WO1996016086A1 Methods for treatment of multiple sclerosis using peptide analogs of human myelin basic protein
05/30/1996WO1996016085A1 Methods for treatment of multiple sclerosis using peptide analogues at position 91 of human myelin basic protein
1 ... 1647 1648 1649 1650 1651 1652 1653 1654 1655 1656 1657 1658 1659 1660 1661 1662 1663 1664 1665 1666 1667 ... 1833